| NDC Code | 45802-104-01 |
|---|
| Package Description | 1 BOTTLE in 1 CARTON (45802-104-01) / 240 SPRAY in 1 BOTTLE |
|---|
| Product NDC | 45802-104 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Olopatadine Hydrochloride |
|---|
| Non-Proprietary Name | Olopatadine Hydrochloride |
|---|
| Dosage Form | SPRAY |
|---|
| Usage | NASAL |
|---|
| Start Marketing Date | 20170614 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA202853 |
|---|
| Manufacturer | Padagis Israel Pharmaceuticals Ltd |
|---|
| Substance Name | OLOPATADINE HYDROCHLORIDE |
|---|
| Strength | 665 |
|---|
| Strength Unit | ug/1 |
|---|
| Pharmacy Classes | Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC] |
|---|